Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $32.67 USD
Change Today -0.62 / -1.86%
Volume 394.4K
EBS On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by EMERGENT BIOSOLUTIONS INC (EBS) in the last 6 months

Announced 08/6/15
Emergent BioSolutions, Inc., Biosciences Business
Spin-Off/Split-Off

Emergent BioSolutions, Inc. (NYSE:EBS) agreed to spin-off Biosciences Business on August 6, 2015. The new Biosciences company will be named later on. Emergent will maintain its headquarters in Gaithersburg, Maryland and other facilities as well. Emergent expects to provide the new company with a fixed cash contribution of $50 million to $70 million. Emergent and the new company will have separate management teams and boards of directors. Daniel J. Abdun-Nabi will remain ...
Read More


EBS's price was unchanged after the transaction was announced on 08/6/15.
Creditor / Lender
Emergent BioSolutions, Inc.
 
Announced 05/28/15
Emergent BioSolutions, Inc., Plasma Collection Facility
Merger/Acquisition

ProMetic Life Sciences Inc. (TSX:PLI) agreed to acquire Plasma Collection Facility from Emergent BioSolutions, Inc. (NYSE:EBS) on May 28, 2015. All existing centre employees will then transition to be employed by ProMetic. The transaction is subject to customary closing conditions.


EBS's price was unchanged after the transaction was announced on 05/28/15.
Investor / Buyer
ProMetic Life Sciences Inc.
Creditor / Lender
Emergent BioSolutions, Inc.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $32.67 USD -0.62

EBS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Albany Molecular Research Inc $19.60 USD -0.34
Bavarian Nordic A/S kr288.00 DKK -4.50
Depomed Inc $26.08 USD -0.85
Impax Laboratories Inc $40.63 USD -0.33
Nektar Therapeutics $10.75 USD -0.30
View Industry Companies
 

Industry Analysis

EBS

Industry Average

Valuation EBS Industry Range
Price/Earnings 34.6x
Price/Sales 2.7x
Price/Book 2.3x
Price/Cash Flow 29.0x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.